Corporate digest
Add BT as a preferred sourceDeeperDive is a beta AI feature. Refer to full articles for the facts.
Trendlines Group
CATALIST-LISTED Trendlines Group, the Israel-based group which focuses on early-stage, high growth innovation-based medical and agricultural technologies, has signed a definitive agreement to sell its BioSight Ltd shares to Arkin Bio Ventures Limited Partnership that will bring it pre-tax proceeds of about US$1.3 million.
"BioSight developed a technology and pipeline of cancer drugs that target and release therapeutic drugs inside cancer cells to reduce systemic toxicity associated with conventional chemotherapy treatments," Trendlines said.
Copyright SPH Media. All rights reserved.
TRENDING NOW
Ministry of Home Affairs Permanent Secretary Pang Kin Keong to retire
Shelving S$5 billion office redevelopment plan proved ‘wise’ as geopolitical risks mount: OCBC chairman
Richard Eu on how core values, customers keep Singapore’s TCM chain Eu Yan Sang relevant
China pips the US if Asean is forced to choose, but analysts warn against reading it like a sports result
